Discover 112 paid clinical trials in Fort Wayne, Indiana. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 112
Active & Responsive
A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)
for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Location: Fort Wayne IN, Grand Rapids MI, Edgewood KY, Madison WI,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06136559
Phase3, Recruiting
Active & Responsive
Device Global Registry for the IlluminOss Bone Stabilization System
for
Traumatic Fracture, Pathological Fracture
Location: Fort Wayne IN, Pittsburgh PA, Winston-Salem NC,
Sponsor: IlluminOss Medical, Inc.
Sex: All
Age: 50+
Code: NCT05206981
Recruiting
Active & Responsive
A Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants With Locally Advanced Unresected Head and Neck Squamous Cell Carcinoma
for
Neoplasms, Head and Neck
Location: Fort Wayne IN, Cincinnati OH, Lexington KY, Hamilton,
Sponsor: GlaxoSmithKline
Sex: All
Age: 18+
Code: NCT06256588
Phase3, Recruiting
Active & Responsive
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
for
Breast Cancer
Location: Fort Wayne IN, Lansing MI, Cincinnati OH, Chicago IL,
Sponsor: Agendia
Sex: All
Age: 18+
Code: NCT03053193
Recruiting
Active & Responsive
A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)
for
Diffuse Large B-Cell Lymphoma
Location: Fort Wayne IN, Grand Rapids MI, Louisville KY,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06717347
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
LGMD R1 Natural History Study
for
Calpain-3 Deficiency Limb Girdle Muscular Dystrophy Type 2A,
Location: Shipshewana IN, Columbus OH, St Louis MO, Iowa City IA,
Sponsor: Virginia Commonwealth University
Sex: All
Age: 12 - 50
Code: NCT05618080
Recruiting
Active & Responsive
Phase 2b Imaging Study of RAD101 in Participants With Suspected Recurrent Brain Metastases
for
Brain Metastases From Solid Tumors
Location: Goshen IN, Ann Arbor MI, Grand Rapids MI, Detroit MI,
Sponsor: Radiopharm Theranostics, Ltd
Sex: All
Age: 18+
Code: NCT06777433
Phase2, Recruiting
Active & Responsive
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
for
Advanced Non-Small Cell Lung Cancer,
Location: Goshen IN, Kettering OH, Columbus OH, Cincinnati OH,
Sponsor: Mirati Therapeutics Inc.
Sex: All
Age: 18+
Code: NCT04613596
Phase2, Phase3, Recruiting
New
Proximal FEmur Reconstruction or Internal Fixation fOR Metastases (PERFORM) Trial
for
Metastatic Bone Disease
Location: Fort Wayne IN, Corvallis OR
Sponsor: Michelle Ghert, MD
Sex: All
Age: 18+
Code: NCT06863129
Recruiting
Study to Learn More About the Safety and Effectiveness of the Drug VITRAKVI During Routine Use in Patients With TRK Fusion Cancer Which is Locally Advanced or Spread From the Place Where it Started to Other Places in the Body
Location: Fort Wayne IN, Lansing MI, Farmington Hills MI,